EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
14.09.23
/
50%
€10.20
Target price
14.09.24
€29.02
Performance (%)
-16.18%
Price
12.07.24
€9.48
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.18%. This prediction currently runs until 14.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | - | - |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $31.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
14.24%
12.07.24
12.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-5.00%
12.07.24
12.07.24